SEARCH RESULT

Total Matching Records found : 1598

New trends of killing the girl child-Kavita Kumari

-ANI   The U.N. Department of Economic and Social Affairs report indicating that India is not a safe place for the girl child hit the headlines in many newspapers and news channels in the country.   Indian society has been known for its preference for the male child.   Among the 150 countries surveyed, including countries classified as LDR (Less Developed Regions), India has the highest rate of female child mortality.   According to this new data -...

More »

5.3 % share for children in Budget-Aarti Dhar

As much as 5.3 per cent of the Union Budget for 2012-13 is Budget for Children (BfC) with an increase of 0.3 per cent since 2011-12. This must be set against the inflation rate of 6.6 per cent. The increase can be attributed to the increased allocation in the development sector by 66.2 per cent and health by 29.7 per cent. However, as always, the share of the protection sector remains...

More »

A historic move to make drugs affordable-G Ananthakrishnan

India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...

More »

Natco Pharma bags licence to sell Bayer's cancer drug Nexavar

-The Economic Times   The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

More »

Natco Pharma bags licence to sell Bayer's cancer drug Nexavar

-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close